|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.70 TWD | +4.52% |
|
+16.37% | +7.48% |
| 12/01 | Nan Ya Plastics 2025 revenue T$259.9 billion, +0.1% Y/Y | RE |
| 16/12 | Nan Ya Plastics plans to invest up to T$210 mln in Aventacell Medical Inc | RE |
| Capitalization | 513B 16.23B 13.89B 12.92B 12.05B 22.51B 1,462B 24.14B 149B 58.51B 700B 60.85B 59.6B 2,565B | P/E ratio 2025 * |
115x | P/E ratio 2026 * | 33.2x |
|---|---|---|---|---|---|
| Enterprise value | 612B 19.34B 16.56B 15.4B 14.36B 26.83B 1,743B 28.78B 177B 69.75B 834B 72.54B 71.05B 3,058B | EV / Sales 2025 * |
2.32x | EV / Sales 2026 * | 2.13x |
| Free-Float |
61.88% | Yield 2025 * |
1.03% | Yield 2026 * | 2.43% |
| 1 day | +4.52% | ||
| 1 week | +16.37% | ||
| Current month | +7.48% | ||
| 1 month | +5.89% | ||
| 3 months | +51.88% | ||
| 6 months | +142.78% | ||
| Current year | +7.48% |
| 1 week | 60 | 70 | |
| 1 month | 55.1 | 70 | |
| Current year | 55.1 | 70 | |
| 1 year | 26.25 | 70 | |
| 3 years | 26.25 | 81.2 | |
| 5 years | 26.25 | 94 | |
| 10 years | 26.25 | 94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Jen Tsou
CEO | Chief Executive Officer | - | 01/07/2015 |
Li Ta Pai
DFI | Director of Finance/CFO | - | 11/08/2022 |
Hsin Yi Huang
PRN | Corporate Officer/Principal | - | 28/08/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Ruey Yue Wang
BRD | Director/Board Member | - | 22/06/2007 |
Chih Kang Wang
BRD | Director/Board Member | - | 11/06/2009 |
Shen Yi Li
BRD | Director/Board Member | - | 22/06/2007 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.52% | +16.37% | +128.62% | -12.92% | 16.23B | ||
| -0.69% | +0.47% | +0.81% | +20.95% | 107B | ||
| -0.18% | +9.89% | -17.69% | -42.03% | 43.96B | ||
| -1.52% | +1.05% | +18.57% | -14.32% | 35.08B | ||
| -0.74% | -5.61% | -1.10% | +184.96% | 33.3B | ||
| -2.37% | +3.00% | +52.66% | +44.67% | 22.88B | ||
| -2.32% | -0.67% | +17.04% | +53.00% | 20.2B | ||
| -0.90% | +3.33% | +195.63% | +228.23% | 19.21B | ||
| +0.57% | +3.98% | +97.31% | -9.26% | 19.26B | ||
| +0.32% | -2.82% | +214.72% | +280.37% | 15.98B | ||
| Average | -0.32% | -0.52% | +70.66% | +73.37% | 33.33B | |
| Weighted average by Cap. | -0.55% | +0.06% | +37.88% | +49.88% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 264B 8.35B 7.15B 6.65B 6.2B 11.58B 753B 12.43B 76.61B 30.11B 360B 31.32B 30.68B 1,320B | 274B 8.65B 7.41B 6.89B 6.42B 12B 780B 12.87B 79.38B 31.2B 373B 32.45B 31.78B 1,368B |
| Net income | 3.96B 125M 107M 99.63M 92.89M 174M 11.28B 186M 1.15B 451M 5.39B 469M 460M 19.78B | 15.46B 489M 419M 389M 363M 678M 44.06B 727M 4.48B 1.76B 21.08B 1.83B 1.8B 77.29B |
| Net Debt | 98.53B 3.12B 2.67B 2.48B 2.31B 4.32B 281B 4.64B 28.58B 11.24B 134B 11.68B 11.45B 493B | 70.59B 2.23B 1.91B 1.78B 1.66B 3.1B 201B 3.32B 20.48B 8.05B 96.25B 8.37B 8.2B 353B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/01/26 | 64.70 NT$ | +4.52% | 88,763,060 |
| 09/01/26 | 61.90 NT$ | -7.61% | 182,653,600 |
| 08/01/26 | 67.00 NT$ | +3.55% | 258,690,300 |
| 07/01/26 | 64.70 NT$ | +9.85% | 206,471,200 |
| 06/01/26 | 58.90 NT$ | +5.94% | 83,767,180 |
End-of-day quote Taiwan S.E., 12 January 2026
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 1303 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















